Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood Cancer Journal

Topics

Biology

Bioinformatics

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.1038/s41408-024-01080-0

License

CC-BY

Other Formats

PDF